Catherine, Princess of Wales, to Make First Official Trip Abroad Since Cancer Diagnosis
Catherine, Princess of Wales, arrived in Italy on Wednesday for her first official overseas engagement since her battle…
Erasca touts strong early results in pancreatic and lung cancer therapy trial
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Supreme Court Appears Divided Over Roundup Weedkiller Case
The Supreme Court appeared divided on Monday during arguments in a dispute that could determine the fate of…
Toronto man’s HIV in remission after bone marrow transplant to treat cancer
A Toronto man could soon join a small club of people in the world considered cured of HIV…
Ben Sasse on the Senate’s “smack-down nonsense” and his wish for America
Late last year, former Sen. Ben Sasse was diagnosed with pancreatic cancer and given three to four months…
Former Sen. Ben Sasse, dying of cancer, reflects on family, faith and the future of America
Ben Sasse would like a final word. At the age of 54, the former U.S. senator of Nebraska…
Israel’s Benjamin Netanyahu was treated for prostate cancer
JERUSALEM (AP) — Israeli Prime Minister Benjamin Netanyahu said Friday that he has undergone treatment for prostate cancer…
Israel’s Benjamin Netanyahu says he was treated for prostate cancer and is now healthy | National Politics
JERUSALEM (AP) — Israeli Prime Minister Benjamin Netanyahu said Friday that he has undergone treatment for prostate cancer…
Ben Sasse grateful to be in Rev Med’s pancreatic cancer drug trial
When Ben Sasse, a former U.S. senator (R-Neb.), learned he had metastatic pancreatic cancer, he quickly chose action…
4 cancers to make up nearly half of new Canadian cases in 2026: study
A new study by the Canadian Medical Association Journal estimates there will be more than 250,000 new cancer…
Revolution Medicines touts success in pancreatic cancer treatment
Metastatic pancreatic cancer patients who received a targeted pill from Revolution Medicines lived nearly twice as long as…
Replimune skin cancer drug that became FDA flashpoint is rejected again
The Food and Drug Administration on Friday rejected — again — an experimental treatment for advanced skin cancer…